Catalysts
About Earth
Earth Corporation develops and markets home care, insecticide, oral care, gardening, and hygiene solutions in Japan and overseas, increasingly supported by service based and technology driven businesses.
What are the underlying business or industry changes driving this perspective?
- Ongoing global warming and prolonged hot seasons are expanding insect populations and usage occasions for repellents, which should support sustained volume growth in core insecticide brands and lift group revenue over the medium term.
- Rising awareness of hygiene and contamination risks in commercial and institutional settings is driving structural demand for professional sanitation services, positioning the general environment and sanitation business to scale recurring contracts and steadily expand operating margins.
- Acceleration of the overseas strategy in ASEAN, with growing market share in Thailand and restructuring in Vietnam and the Philippines, is likely to shift the sales mix toward higher growth regions and underpin a faster pace of consolidated revenue and earnings expansion.
- Commercial adoption of MA T in healthcare, pet care, and caregiving equipment, supported by industry partnerships and association led standard setting, creates a higher margin technology platform that can contribute incremental profit and support earnings multiples as it reaches single year profitability.
- Portfolio optimization through the PROTOLEAF consolidation, BATHCLIN merger, group reorganization, and the Mondahmin brand renewal should strengthen pricing power and cost efficiency, supporting higher gross margin, operating income growth, and return on equity.
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Earth's revenue will grow by 2.9% annually over the next 3 years.
- Analysts assume that profit margins will increase from 3.0% today to 3.5% in 3 years time.
- Analysts expect earnings to reach ¥6.7 billion (and earnings per share of ¥307.99) by about December 2028, up from ¥5.3 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as ¥5.7 billion.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 23.2x on those 2028 earnings, up from 21.1x today. This future PE is greater than the current PE for the JP Household Products industry at 15.4x.
- Analysts expect the number of shares outstanding to grow by 0.32% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 4.8%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?
- Climate patterns that increasingly swing between unusually cool early summers and short, volatile heat waves could cap long term demand for insecticides and repellents, limiting category growth in Japan and overseas and slowing revenue expansion.
- Execution risk around the BATHCLIN merger, SKU rationalization, and the full scale Mondahmin renewal may lead to brand dilution, lost shelf space, or weaker consumer loyalty, pressuring home care and oral care volumes and weighing on operating margins.
- The overseas strategy is heavily concentrated in ASEAN and currently experiencing underperformance in Vietnam, the Philippines, and China, so prolonged restructuring, inventory issues, or macro weakness in these markets could delay scale benefits and hold back group earnings growth.
- The MA T business is still in the early investment phase, and if real world adoption in healthcare, pet care, and caregiving stalls or competitors introduce superior disinfection technologies, the business may fail to reach meaningful scale, limiting its contribution to high margin revenue and future profit.
- Structural reform costs, higher advertising spend for large scale brand campaigns, and the shift toward a holdings structure create integration and cost overrun risks, which could offset recent gross margin improvements and reduce net income and return on equity.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of ¥6146.67 for Earth based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ¥6800.0, and the most bearish reporting a price target of just ¥5500.0.
- In order for you to agree with the analysts, you'd need to believe that by 2028, revenues will be ¥193.2 billion, earnings will come to ¥6.7 billion, and it would be trading on a PE ratio of 23.2x, assuming you use a discount rate of 4.8%.
- Given the current share price of ¥5080.0, the analyst price target of ¥6146.67 is 17.4% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Earth?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

